Randall D Jenkins
Overview
Explore the profile of Randall D Jenkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jenkins R
Pediatr Nephrol
. 2022 Nov;
38(6):1717-1724.
PMID: 36322257
Since the 1970s, when the initial reports of neonatal hypertension related to renal artery thromboembolism were published, other secondary causes of neonatal hypertension have been reported. Those infants with no...
2.
Gievers L, Jenkins R, Laird A, Macedo M, Schilling D, McEvoy C
Res Rep Neonatol
. 2021 Jun;
9:21-30.
PMID: 34084063
Purpose: Preterm infants are at increased risk of systemic hypertension compared to term infants. Bronchopulmonary dysplasia (BPD) has been shown to be associated with hypertension in preterm infants albeit with...
3.
Jenkins R, Aziz J, Gievers L, Mooers H, Fino N, Rozansky D
Pediatr Nephrol
. 2017 Jul;
32(11):2115-2124.
PMID: 28674750
Background: Many causes for neonatal hypertension in premature infants have been described; however in some cases no etiology can be attributed. Our objectives are to describe such cases of unexplained...
4.
Rosenblatt G, Jenkins R, Barry J
Urology
. 2006 Aug;
68(2):427.e7-8.
PMID: 16904473
Alanine-glyoxalate aminotransferase deficiency occurs in patients with primary hyperoxaluria type 1. Increased hepatic oxalate production leads to high urine concentrations of glycolate and oxalate. Calcium oxalate nephrolithiasis and nephrocalcinosis occur,...
5.
Li J, Berezny K, Kilaru R, Hazan L, Portman R, Hogg R, et al.
Hypertension
. 2004 Jul;
44(3):289-93.
PMID: 15262902
We evaluated the efficacy, safety, and dose-response relationship of fosinopril in children aged 6 to 16 years with hypertension or high-normal blood pressure with an associated medical condition requiring treatment....